Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells

Joanna E. Burdette, Jacqueline S. Jeruss, Sarah J. Kurley, Eun Jig Lee, Teresa K. Woodruff

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

The transforming growth factor-β (TGF-β) superfamily of growth factors is responsible for a variety of physiologic actions, including cell cycle regulation. Activin is a member of the TGF-β superfamily that inhibits the proliferation of breast cancer cells. Activin functions by interacting with its type I and type II receptors to induce phosphorylation of intracellular signaling molecules known as Smads. Smads regulate transcription of many genes in a cell- and tissue-specific manner. In this study, the role of activin A in growth regulation of breast cancer cells was investigated. Activin stimulated the Smad-responsive promoter, p3TP, 2-fold over control in T47D breast cancer cells. Activin inhibited cellular proliferation of T47D breast cancer cells after 72 hours, an effect that could be abrogated by incubation with the activin type I receptor inhibitor, SB431542. Activin arrested T47D cells in the G0-G1 cell cycle phase. Smad2 and Smad3 were phosphorylated in response to activin and accumulated in the nucleus of treated T47D cells. Infection of T47D cells with adenoviral Smad3 resulted in cell cycle arrest and activation of p3TP-luciferase, whereas a adenoviral dominant-negative Smad3 blocked activin-mediated cell cycle arrest and gene transcription. Activin maintained expression of p21 and p27 cyclin-dependent kinase inhibitors involved in cell cycle control, enhanced expression of p15, reduced cyclin A expression, and reduced phosphorylation of the retinoblastoma (Rb) protein. Smad3 overexpression recapitulated activin-induced p15 expression and repression of cyclin A and Rb phosphorylation. These data indicate that activin A inhibits breast cancer cellular proliferation and activates Smads responsible for initiating cell cycle arrest.

Original languageEnglish
Pages (from-to)7968-7975
Number of pages8
JournalCancer Research
Volume65
Issue number17
DOIs
Publication statusPublished - 2005 Sep 1

Fingerprint

Activins
Cell Cycle Checkpoints
Breast Neoplasms
Growth
Cyclin A
Phosphorylation
Transforming Growth Factors
Type I Activin Receptors
Cell Cycle
Cell Proliferation
Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
activin A
cdc Genes
Retinoblastoma Protein
Retinoblastoma
Luciferases
Intercellular Signaling Peptides and Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Burdette, Joanna E. ; Jeruss, Jacqueline S. ; Kurley, Sarah J. ; Lee, Eun Jig ; Woodruff, Teresa K. / Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. In: Cancer Research. 2005 ; Vol. 65, No. 17. pp. 7968-7975.
@article{a3414f7641c04c758228b86d1b0720c7,
title = "Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells",
abstract = "The transforming growth factor-β (TGF-β) superfamily of growth factors is responsible for a variety of physiologic actions, including cell cycle regulation. Activin is a member of the TGF-β superfamily that inhibits the proliferation of breast cancer cells. Activin functions by interacting with its type I and type II receptors to induce phosphorylation of intracellular signaling molecules known as Smads. Smads regulate transcription of many genes in a cell- and tissue-specific manner. In this study, the role of activin A in growth regulation of breast cancer cells was investigated. Activin stimulated the Smad-responsive promoter, p3TP, 2-fold over control in T47D breast cancer cells. Activin inhibited cellular proliferation of T47D breast cancer cells after 72 hours, an effect that could be abrogated by incubation with the activin type I receptor inhibitor, SB431542. Activin arrested T47D cells in the G0-G1 cell cycle phase. Smad2 and Smad3 were phosphorylated in response to activin and accumulated in the nucleus of treated T47D cells. Infection of T47D cells with adenoviral Smad3 resulted in cell cycle arrest and activation of p3TP-luciferase, whereas a adenoviral dominant-negative Smad3 blocked activin-mediated cell cycle arrest and gene transcription. Activin maintained expression of p21 and p27 cyclin-dependent kinase inhibitors involved in cell cycle control, enhanced expression of p15, reduced cyclin A expression, and reduced phosphorylation of the retinoblastoma (Rb) protein. Smad3 overexpression recapitulated activin-induced p15 expression and repression of cyclin A and Rb phosphorylation. These data indicate that activin A inhibits breast cancer cellular proliferation and activates Smads responsible for initiating cell cycle arrest.",
author = "Burdette, {Joanna E.} and Jeruss, {Jacqueline S.} and Kurley, {Sarah J.} and Lee, {Eun Jig} and Woodruff, {Teresa K.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1158/0008-5472.CAN-04-3553",
language = "English",
volume = "65",
pages = "7968--7975",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. / Burdette, Joanna E.; Jeruss, Jacqueline S.; Kurley, Sarah J.; Lee, Eun Jig; Woodruff, Teresa K.

In: Cancer Research, Vol. 65, No. 17, 01.09.2005, p. 7968-7975.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells

AU - Burdette, Joanna E.

AU - Jeruss, Jacqueline S.

AU - Kurley, Sarah J.

AU - Lee, Eun Jig

AU - Woodruff, Teresa K.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - The transforming growth factor-β (TGF-β) superfamily of growth factors is responsible for a variety of physiologic actions, including cell cycle regulation. Activin is a member of the TGF-β superfamily that inhibits the proliferation of breast cancer cells. Activin functions by interacting with its type I and type II receptors to induce phosphorylation of intracellular signaling molecules known as Smads. Smads regulate transcription of many genes in a cell- and tissue-specific manner. In this study, the role of activin A in growth regulation of breast cancer cells was investigated. Activin stimulated the Smad-responsive promoter, p3TP, 2-fold over control in T47D breast cancer cells. Activin inhibited cellular proliferation of T47D breast cancer cells after 72 hours, an effect that could be abrogated by incubation with the activin type I receptor inhibitor, SB431542. Activin arrested T47D cells in the G0-G1 cell cycle phase. Smad2 and Smad3 were phosphorylated in response to activin and accumulated in the nucleus of treated T47D cells. Infection of T47D cells with adenoviral Smad3 resulted in cell cycle arrest and activation of p3TP-luciferase, whereas a adenoviral dominant-negative Smad3 blocked activin-mediated cell cycle arrest and gene transcription. Activin maintained expression of p21 and p27 cyclin-dependent kinase inhibitors involved in cell cycle control, enhanced expression of p15, reduced cyclin A expression, and reduced phosphorylation of the retinoblastoma (Rb) protein. Smad3 overexpression recapitulated activin-induced p15 expression and repression of cyclin A and Rb phosphorylation. These data indicate that activin A inhibits breast cancer cellular proliferation and activates Smads responsible for initiating cell cycle arrest.

AB - The transforming growth factor-β (TGF-β) superfamily of growth factors is responsible for a variety of physiologic actions, including cell cycle regulation. Activin is a member of the TGF-β superfamily that inhibits the proliferation of breast cancer cells. Activin functions by interacting with its type I and type II receptors to induce phosphorylation of intracellular signaling molecules known as Smads. Smads regulate transcription of many genes in a cell- and tissue-specific manner. In this study, the role of activin A in growth regulation of breast cancer cells was investigated. Activin stimulated the Smad-responsive promoter, p3TP, 2-fold over control in T47D breast cancer cells. Activin inhibited cellular proliferation of T47D breast cancer cells after 72 hours, an effect that could be abrogated by incubation with the activin type I receptor inhibitor, SB431542. Activin arrested T47D cells in the G0-G1 cell cycle phase. Smad2 and Smad3 were phosphorylated in response to activin and accumulated in the nucleus of treated T47D cells. Infection of T47D cells with adenoviral Smad3 resulted in cell cycle arrest and activation of p3TP-luciferase, whereas a adenoviral dominant-negative Smad3 blocked activin-mediated cell cycle arrest and gene transcription. Activin maintained expression of p21 and p27 cyclin-dependent kinase inhibitors involved in cell cycle control, enhanced expression of p15, reduced cyclin A expression, and reduced phosphorylation of the retinoblastoma (Rb) protein. Smad3 overexpression recapitulated activin-induced p15 expression and repression of cyclin A and Rb phosphorylation. These data indicate that activin A inhibits breast cancer cellular proliferation and activates Smads responsible for initiating cell cycle arrest.

UR - http://www.scopus.com/inward/record.url?scp=24744446473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24744446473&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-3553

DO - 10.1158/0008-5472.CAN-04-3553

M3 - Article

C2 - 16140969

AN - SCOPUS:24744446473

VL - 65

SP - 7968

EP - 7975

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 17

ER -